Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Varex Imaging CorpVREX · Entity 5135 | Director | February 13, 2020 | February 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Varex Imaging Corp
Report date February 13, 2020 · Filed February 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,085 |
Ending reported balance
After 2020-02-14 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-02-14 · Exercise / conversion · Acquired 15,074 · Balance 28,149 Row 2 · 2020-02-14 · Sale · Disposed 15,074 · Balance 13,075 F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.69 to $26.18. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Row 3 · 2020-02-14 · Exercise / conversion · Acquired 5,148 · Balance 18,223 F2: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Row 4 · 2020-02-14 · Tax withholding · Disposed 138 · Balance 18,085 F3: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Deferred Stock Units reported herein. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,160 |
Reported balance
After 2020-02-13 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-02-13 · Grant · Acquired 6,160 · Balance 6,160 F2: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-02-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-02-14 · Exercise / conversion · Disposed 5,148 · Balance 0 F2: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F6: These Deferred Stock Units vested in four equal quarterly installments over a 12 month period beginning February 16, 2017. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2020. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.24 · Expires 2020-02-15 | Direct | 0 |
Reported balance
After 2020-02-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-02-14 · Exercise / conversion · Disposed 15,074 · Balance 0 F5: Option vested 100% immediately on February 15, 2013. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.69 to $26.18. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F3: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Deferred Stock Units reported herein.
F4: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason.
F5: Option vested 100% immediately on February 15, 2013.
F6: These Deferred Stock Units vested in four equal quarterly installments over a 12 month period beginning February 16, 2017. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2020 Filed Feb 18, 2020 20:00 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 5,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000013 · wf-form4_158207401308251.xml · derivative · entry 7 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Deferred Stock Units vested in four equal quarterly installments over a 12 month period beginning February 16, 2017. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2020. F6 · derivative.expiration_date: These Deferred Stock Units vested in four equal quarterly installments over a 12 month period beginning February 16, 2017. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2020. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 20:00 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,074 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001681622-20-000013 · wf-form4_158207401308251.xml · derivative · entry 6 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,074 shares Expires 2020-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option vested 100% immediately on February 15, 2013. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 20:00 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 138 | $25.89 | $3,572.82 |
DisclosureSEC source: 0001681622-20-000013 · wf-form4_158207401308251.xml · nonDerivative · entry 4 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,085 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Deferred Stock Units reported herein. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 20:00 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-20-000013 · wf-form4_158207401308251.xml · nonDerivative · entry 3 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 20:00 UTC | Varex Imaging Corp VREX · Entity 5135 | SaleCommon Stock | 15,074 | $25.91 | $390,567.34 |
DisclosureSEC source: 0001681622-20-000013 · wf-form4_158207401308251.xml · nonDerivative · entry 2 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,075 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.69 to $26.18. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 20:00 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 15,074 | $23.24 | $350,319.76 |
DisclosureSEC source: 0001681622-20-000013 · wf-form4_158207401308251.xml · nonDerivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 20:00 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000013 · wf-form4_158207401308251.xml · derivative · entry 5 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 6,160 shares Expires not disclosed F2 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F4 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000024 · wf-form4_155062418903262.xml · derivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,098 Underlying: Common Shares · 5,098 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 3 years from grant date, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 3 years from grant date, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:41 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 6,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000012 · wf-form4_155019129527013.xml · derivative · entry 3 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,358 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 12, 2019. F3 · derivative.expiration_date: Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 12, 2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:41 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 1,272 | $31.42 | $39,966.24 |
DisclosureSEC source: 0001681622-19-000012 · wf-form4_155019129527013.xml · nonDerivative · entry 2 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,075 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Deferred Stock Units reported herein. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:41 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 6,358 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-19-000012 · wf-form4_155019129527013.xml · nonDerivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:55 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-001430 · marketforms-41085.xml · derivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,312 Underlying: Common Stock · 4,312 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% 1 year from grant date (February 15, 2018). Vested shares will be delivered to the reporting person upon the earlier of (i) the NEDs termination of service for any reason, (ii) 3 years from grant date, (iii) a change in control, or (iv) upon death. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% 1 year from grant date (February 15, 2018). Vested shares will be delivered to the reporting person upon the earlier of (i) the NEDs termination of service for any reason, (ii) 3 years from grant date, (iii) a change in control, or (iv) upon death. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 19:31 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 5,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-001336 · marketforms-41021.xml · derivative · entry 3 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,207 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Deferred Stock Units fully vested on February 13, 2016. Pursuant to the terms of the applicable grant agreement, payment, in the form of shares of common stock, became due on February 13, 2018. F4 · derivative.expiration_date: The Deferred Stock Units fully vested on February 13, 2016. Pursuant to the terms of the applicable grant agreement, payment, in the form of shares of common stock, became due on February 13, 2018. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 19:31 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 2,187 | $36.21 | $79,191.27 |
DisclosureSEC source: 0001214659-18-001336 · marketforms-41021.xml · nonDerivative · entry 2 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,989 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Deferred Stock Units reported herein. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 19:31 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,207 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-18-001336 · marketforms-41021.xml · nonDerivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Includes 480 shares acquired as a share dividend in connection with the company's separation from Varian Medical Systems, Inc. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 18:22 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionDeferred Stock Units · Derivative | 5,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001332 · marketforms-38012.xml · derivative · entry 3 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,489 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units were fully vested on February 21, 2015. Vested shares will be delivered to the reporting person the earlier of three (3) years from February 21, 2014 or termination date. F3 · derivative.expiration_date: These Deferred Stock Units were fully vested on February 21, 2015. Vested shares will be delivered to the reporting person the earlier of three (3) years from February 21, 2014 or termination date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 18:22 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 1,275 | $33.21 | $42,342.75 |
DisclosureSEC source: 0001214659-17-001332 · marketforms-38012.xml · nonDerivative · entry 2 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,489 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Deferred Stock Units reported herein. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 18:22 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-17-001332 · marketforms-38012.xml · nonDerivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:31 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 5,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001258 · marketforms-37989.xml · derivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,477 Underlying: Common Stock · 5,148 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 16, 2017. Vested shares will be delivered to the reporting person the earlier of four years from the grant date or termination date. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 16, 2017. Vested shares will be delivered to the reporting person the earlier of four years from the grant date or termination date. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:04 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000584 · marketforms-37685.xml · derivative · entry 4 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F3 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · derivative.exercise_date: These DSUs vest in four equal quarterly installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These DSUs vest in four equal quarterly installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:04 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000584 · marketforms-37685.xml · derivative · entry 3 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F3 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · derivative.exercise_date: These DSUs vest in four equal quarterly installments beginning on February 13, 2016. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These DSUs vest in four equal quarterly installments beginning on February 13, 2016. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:04 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000584 · marketforms-37685.xml · derivative · entry 2 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F3 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F4 · derivative.exercise_date: These DSUs vest in four equal quarterly installments beginning on February 21, 2015. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These DSUs vest in four equal quarterly installments beginning on February 21, 2015. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. Once the number of shares of the Issuer's common stock underlying this DSU award has been determined, an amended Form 4 will be filed disclosing such information. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:04 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000584 · marketforms-37685.xml · derivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2020-02-21 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F2 · derivative.exercise_date: Option is subject to vest 100% immediately on February 15, 2013. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 6,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000912 · marketforms-37815.xml · derivative · entry 4 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 6,358 shares Expires 2020-02-12 F3 · derivative.exercise_price: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · derivative.exercise_date: These DSUs vest one year in four (4) equal quarterly installments over a 12 month period beginning February 12, 2016. Vested shares will be delivered the earlier of three (3) years from February 12, 2016 or termination date. F6 · derivative.expiration_date: These DSUs vest one year in four (4) equal quarterly installments over a 12 month period beginning February 12, 2016. Vested shares will be delivered the earlier of three (3) years from February 12, 2016 or termination date. F3 · derivative.underlying_shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 5,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000912 · marketforms-37815.xml · derivative · entry 3 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 5,207 shares Expires 2019-02-13 F3 · derivative.exercise_price: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · derivative.exercise_date: These DSUs were fully vested on February 13, 2016. Vested shares will be delivered the earlier of three (3) years from February 13, 2015 or termination date. F5 · derivative.expiration_date: These DSUs were fully vested on February 13, 2016. Vested shares will be delivered the earlier of three (3) years from February 13, 2015 or termination date. F3 · derivative.underlying_shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 5,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000912 · marketforms-37815.xml · derivative · entry 2 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 5,764 shares Expires 2018-02-21 F3 · derivative.exercise_price: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F4 · derivative.exercise_date: These DSUs were fully vested on February 21, 2015. Vested shares will be delivered the earlier of three (3) years from February 21, 2014 or termination date. F4 · derivative.expiration_date: These DSUs were fully vested on February 21, 2015. Vested shares will be delivered the earlier of three (3) years from February 21, 2014 or termination date. F3 · derivative.underlying_shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,074 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001214659-17-000912 · marketforms-37815.xml · derivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,074 Underlying: Common Stock · 15,074 shares Expires 2020-02-15 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F2 · derivative.exercise_date: Option vested 100% immediately on February 15, 2013. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.